Sonoma Pharmaceuticals (SNOA) Revenue & Revenue Breakdown
Sonoma Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$12.73M
Latest Revenue (Q)
$3.44M
Main Segment (Y)
Human Care
Main Geography (Y)
Service
Sonoma Pharmaceuticals Revenue by Period
Sonoma Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $12.73M | -4.05% |
| 2023-03-31 | $13.27M | 5.10% |
| 2022-03-31 | $12.63M | -32.21% |
| 2021-03-31 | $18.63M | -1.62% |
| 2020-03-31 | $18.94M | -0.18% |
| 2019-03-31 | $18.97M | 13.88% |
| 2018-03-31 | $16.66M | 29.89% |
| 2017-03-31 | $12.82M | -14.98% |
| 2016-03-31 | $15.08M | 8.88% |
| 2015-03-31 | $13.85M | 1.36% |
| 2014-03-31 | $13.67M | -11.55% |
| 2013-03-31 | $15.45M | 21.25% |
| 2012-03-31 | $12.74M | 30.65% |
| 2011-03-31 | $9.75M | 32.46% |
| 2010-03-31 | $7.36M | 36.67% |
| 2009-03-31 | $5.39M | 40.50% |
| 2008-03-31 | $3.83M | -15.58% |
| 2007-03-31 | $4.54M | 75.81% |
| 2006-03-31 | $2.58M | 90.56% |
| 2005-03-31 | $1.36M | 50.33% |
| 2004-03-31 | $902.00K | -63.48% |
| 2003-03-31 | $2.47M | 23.50% |
| 2002-03-31 | $2.00M | - |
Sonoma Pharmaceuticals generated $12.73M in revenue during NA 2024, up -4.05% compared to the previous quarter, and up 67.13% compared to the same period a year ago.
Sonoma Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $3.44M | 9.59% |
| 2023-12-31 | $3.14M | 14.90% |
| 2023-09-30 | $2.73M | -20.31% |
| 2023-06-30 | $3.43M | 13.70% |
| 2023-03-31 | $3.01M | 2.38% |
| 2022-12-31 | $2.94M | -11.62% |
| 2022-09-30 | $3.33M | -16.37% |
| 2022-06-30 | $3.98M | 73.32% |
| 2022-03-31 | $2.30M | -20.81% |
| 2021-12-31 | $2.90M | -22.49% |
| 2021-09-30 | $3.74M | 1.63% |
| 2021-06-30 | $3.68M | 70.79% |
| 2021-03-31 | $2.16M | -56.30% |
| 2020-12-31 | $4.94M | -14.44% |
| 2020-09-30 | $5.77M | -20.47% |
| 2020-06-30 | $7.25M | 58.42% |
| 2020-03-31 | $4.58M | -2.12% |
| 2019-12-31 | $4.68M | -5.84% |
| 2019-09-30 | $4.97M | 5.46% |
| 2019-06-30 | $4.71M | 7.51% |
| 2019-03-31 | $4.38M | -17.01% |
| 2018-12-31 | $5.28M | 6.90% |
| 2018-09-30 | $4.94M | 13.05% |
| 2018-06-30 | $4.37M | 19.53% |
| 2018-03-31 | $3.65M | -24.53% |
| 2017-12-31 | $4.84M | 11.98% |
| 2017-09-30 | $4.33M | 12.78% |
| 2017-06-30 | $3.83M | -4.82% |
| 2017-03-31 | $4.03M | 19.88% |
| 2016-12-31 | $3.36M | -18.18% |
| 2016-09-30 | $4.11M | 7.79% |
| 2016-06-30 | $3.81M | 7.96% |
| 2016-03-31 | $3.53M | -7.59% |
| 2015-12-31 | $3.82M | -5.77% |
| 2015-09-30 | $4.05M | 10.16% |
| 2015-06-30 | $3.68M | -7.54% |
| 2015-03-31 | $3.98M | 23.68% |
| 2014-12-31 | $3.22M | -1.41% |
| 2014-09-30 | $3.26M | -3.77% |
| 2014-06-30 | $3.39M | 16.40% |
| 2014-03-31 | $2.91M | -11.51% |
| 2013-12-31 | $3.29M | -19.47% |
| 2013-09-30 | $4.09M | 21.26% |
| 2013-06-30 | $3.37M | 1.11% |
| 2013-03-31 | $3.33M | -5.79% |
| 2012-12-31 | $3.54M | -21.79% |
| 2012-09-30 | $4.53M | 11.73% |
| 2012-06-30 | $4.05M | 20.89% |
| 2012-03-31 | $3.35M | 20.11% |
| 2011-12-31 | $2.79M | -23.83% |
| 2011-09-30 | $3.66M | 24.59% |
| 2011-06-30 | $2.94M | 8.45% |
| 2011-03-31 | $2.71M | 17.21% |
| 2010-12-31 | $2.31M | -6.20% |
| 2010-09-30 | $2.47M | 8.92% |
| 2010-06-30 | $2.26M | 1.43% |
| 2010-03-31 | $2.23M | 38.38% |
| 2009-12-31 | $1.61M | -3.53% |
| 2009-09-30 | $1.67M | -9.47% |
| 2009-06-30 | $1.85M | 25.22% |
| 2009-03-31 | $1.48M | 20.80% |
| 2008-12-31 | $1.22M | -17.56% |
| 2008-09-30 | $1.48M | 22.30% |
| 2008-06-30 | $1.21M | 30.78% |
| 2008-03-31 | $926.00K | -13.13% |
| 2007-12-31 | $1.07M | - |
Sonoma Pharmaceuticals generated $3.44M in revenue during Q4 2024, up 9.59% compared to the previous quarter, and up 116.81% compared to the same period a year ago.
Sonoma Pharmaceuticals Revenue Breakdown
Sonoma Pharmaceuticals Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| Service And Royalty | $422.00K | - | - | - | - |
| Animal Care | $2.20M | - | - | - | - |
| Human Care | $10.11M | - | - | - | - |
| Shipping and Handling | - | $42.00K | $52.00K | $37.00K | - |
| Service | - | - | $349.00K | $112.00K | - |
| Product | - | - | - | - | $15.69M |
Sonoma Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Mar 24: Human Care (79.39%), Animal Care (17.30%), and Service And Royalty (3.31%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Mar 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Animal Care | $1.09M | $621.00K | $489.00K | $414.00K | $818.00K | $1.00M | $812.00K | $1.36M | $951.00K | $377.00K | - | - | - | - | - | - |
| Human Care | $5.57M | $2.46M | $2.08M | $1.81M | $2.02M | $2.59M | $2.71M | $3.53M | $4.78M | $6.86M | - | - | - | - | - | - |
| Service And Royalty | $199.00K | $56.00K | $167.00K | $69.00K | $148.00K | $157.00K | - | - | - | - | - | - | - | - | - | - |
| Service | - | - | - | $99.00K | $75.00K | $147.00K | $1.03M | $280.00K | - | - | - | - | - | - | - | - |
| Other Sales | - | - | - | - | - | - | - | - | - | - | - | $45.00K | $42.00K | $13.00K | - | - |
| Product | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $4.11M |
Sonoma Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Human Care (81.18%), Animal Care (15.92%), and Service And Royalty (2.90%).
Sonoma Pharmaceuticals Revenue Breakdown by Country
Annual Revenue by Country
| Country | Mar 22 |
|---|---|
| Shipping and Handling | $52.00K |
| Service | $349.00K |
Sonoma Pharmaceuticals's latest annual revenue breakdown by geography, as of Mar 22: Service (87.03%), and Shipping and Handling (12.97%).
Quarterly Revenue by Country
| Country | Dec 20 | Sep 20 | Jun 20 |
|---|---|---|---|
| Europe and Rest of the World | $1.65M | $1.76M | $3.21M |
| UNITED STATES | $1.98M | $1.98M | $1.72M |
| Latin America | $1.31M | $2.02M | $2.32M |
Sonoma Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Dec 20: UNITED STATES (40.07%), Europe and Rest of the World (33.45%), and Latin America (26.48%).
Sonoma Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PTPI | Petros Pharmaceuticals | $5.82B | $1.39M |
| LFCR | Lifecore Biomedical | $128.26M | $35.70M |
| ACOR | Acorda Therapeutics | $102.42M | $20.29M |
| ALIM | Alimera Sciences | $80.75M | $23.01M |
| DERM | Journey Medical | $79.18M | $14.86M |
| SBFM | Sunshine Biopharma | $39.85M | $9.30M |
| TKNO | Alpha Teknova | $36.68M | $9.61M |
| UPC | Universe Pharmaceuticals | $32.31M | $13.84M |
| SNOA | Sonoma Pharmaceuticals | $12.73M | $3.44M |
| GHSI | Guardion Health Sciences | $12.25M | $36.35K |
| AKAN | Akanda | $2.16M | $762.61K |
| SXTC | China SXT Pharmaceuticals | $1.97M | $939.58K |
| SHPH | Shuttle Pharmaceuticals | - | - |
SNOA Revenue FAQ
What is Sonoma Pharmaceuticals’s yearly revenue?
Sonoma Pharmaceuticals's yearly revenue for 2024 was $12.74M, representing a decrease of -4.05% compared to 2023. The company's yearly revenue for 2023 was $13.27M, representing an increase of 5.10% compared to 2022. SNOA's yearly revenue for 2022 was $12.63M, representing a decrease of -32.21% compared to 2021.
What is Sonoma Pharmaceuticals’s quarterly revenue?
Sonoma Pharmaceuticals's quarterly revenue for Q4 2024 was $3.44M, a 9.59% increase from the previous quarter (Q3 2024), and a 14.10% increase year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $3.14M, a 14.90% increase from the previous quarter (Q2 2024), and a 6.59% increase year-over-year (Q3 2023). SNOA's quarterly revenue for Q2 2024 was $2.73M, a -20.31% decrease from the previous quarter (Q1 2024), and a -18.01% decrease year-over-year (Q2 2023).
What is Sonoma Pharmaceuticals’s revenue growth rate?
Sonoma Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 0.85%, and for the last 5 years (2020-2024) was -32.75%.
What are Sonoma Pharmaceuticals’s revenue streams?
Sonoma Pharmaceuticals's revenue streams in r 24 are Service And Royalty, Animal Care, and Human Care. Service And Royalty generated $422K in revenue, accounting 3.31% of the company's total revenue Animal Care generated $2.2M in revenue, accounting 17.30% of the company's total revenue Human Care generated $10.11M in revenue, accounting 79.39% of the company's total revenue
What is Sonoma Pharmaceuticals’s main source of revenue?
For the fiscal year ending Mar 24, the largest source of revenue of Sonoma Pharmaceuticals was Human Care. This segment made a revenue of $10.11M, representing 79.39% of the company's total revenue.